Independence Bank of Kentucky Invests $39,000 in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Independence Bank of Kentucky purchased a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the 4th quarter, Holdings Channel.com reports. The firm purchased 4,200 shares of the pharmacy operator’s stock, valued at approximately $39,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. First Financial Corp IN boosted its stake in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 885 shares during the period. TD Private Client Wealth LLC raised its holdings in shares of Walgreens Boots Alliance by 8,670.3% in the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after buying an additional 3,208 shares during the last quarter. Sentry Investment Management LLC acquired a new stake in shares of Walgreens Boots Alliance during the third quarter worth about $30,000. Eastern Bank acquired a new position in Walgreens Boots Alliance in the 3rd quarter valued at about $33,000. Finally, Brooklyn Investment Group purchased a new stake in Walgreens Boots Alliance during the 3rd quarter valued at approximately $35,000. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Trading Down 10.3 %

NASDAQ:WBA opened at $10.28 on Monday. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $23.76. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The stock has a fifty day simple moving average of $10.12 and a 200-day simple moving average of $9.85. The company has a market capitalization of $8.88 billion, a PE ratio of -1.00, a price-to-earnings-growth ratio of 1.41 and a beta of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. During the same quarter in the prior year, the firm earned $0.66 earnings per share. The company’s revenue for the quarter was up 7.6% compared to the same quarter last year. On average, equities research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the company. Royal Bank of Canada boosted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a report on Wednesday, January 15th. Morgan Stanley cut their price objective on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research report on Friday, October 11th. UBS Group lifted their target price on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Thursday, October 17th. Evercore ISI increased their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. Finally, Truist Financial lowered their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $13.19.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.